Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Stem cell-based strategies for treating pediatric disorders of myelin.

Goldman SA, Schanz S, Windrem MS.

Hum Mol Genet. 2008 Apr 15;17(R1):R76-83. doi: 10.1093/hmg/ddn052. Review.

2.

Glial progenitor-based repair of demyelinating neurological diseases.

Keyoung HM, Goldman SA.

Neurosurg Clin N Am. 2007 Jan;18(1):93-104, x. Review.

PMID:
17244557
3.
4.

Glial precursor cell transplantation therapy for neurotrauma and multiple sclerosis.

Kulbatski I, Mothe AJ, Parr AM, Kim H, Kang CE, Bozkurt G, Tator CH.

Prog Histochem Cytochem. 2008;43(3):123-76. doi: 10.1016/j.proghi.2008.04.001. Review.

PMID:
18706353
5.

Prospects of cell therapy for disorders of myelin.

Ben-Hur T, Goldman SA.

Ann N Y Acad Sci. 2008 Oct;1142:218-49. doi: 10.1196/annals.1444.014. Review.

PMID:
18990129
6.

Fate determination of adult human glial progenitor cells.

Sim FJ, Windrem MS, Goldman SA.

Neuron Glia Biol. 2009 Nov;5(3-4):45-55. doi: 10.1017/S1740925X09990317. Review.

PMID:
19807941
7.

Progenitor cell-based myelination as a model for cell-based therapy of the central nervous system.

Goldman SA, Lang J, Roy N, Schanz SJ, Sim FS, Wang S, Washco V, Windrem MS.

Ernst Schering Res Found Workshop. 2006;(60):195-213. Review.

PMID:
16903424
8.

[Development and regeneration of oligodendrocytes: therapeutic perspectives in demyelinating diseases].

Dubois-Dalcq M.

Bull Mem Acad R Med Belg. 2005;160(10-12):407-15; discussion 415-6. French.

PMID:
16768245
9.

Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse.

Windrem MS, Schanz SJ, Guo M, Tian GF, Washco V, Stanwood N, Rasband M, Roy NS, Nedergaard M, Havton LA, Wang S, Goldman SA.

Cell Stem Cell. 2008 Jun 5;2(6):553-65. doi: 10.1016/j.stem.2008.03.020.

10.

Glial progenitor cell transplantation and the generation of chimeric animal models with human brain cells: implications for novel therapeutics.

Munoz-Sanjuan I.

Expert Opin Ther Pat. 2009 Dec;19(12):1639-46. doi: 10.1517/13543770903443105. Review.

PMID:
19939186
11.

Remyelination: cellular and gene therapy.

Billinghurst LL, Taylor RM, Snyder EY.

Semin Pediatr Neurol. 1998 Sep;5(3):211-28. Review.

PMID:
9777679
12.
13.

Canavan disease: a white matter disorder.

Kumar S, Mattan NS, de Vellis J.

Ment Retard Dev Disabil Res Rev. 2006;12(2):157-65. Review.

PMID:
16807907
14.

Glial progenitor cell-based treatment and modeling of neurological disease.

Goldman SA, Nedergaard M, Windrem MS.

Science. 2012 Oct 26;338(6106):491-5. doi: 10.1126/science.1218071. Review.

15.

Leukodystrophies: pathogenesis, diagnosis, strategies, therapies, and future research directions.

Maria BL, Deidrick KM, Moser H, Naidu S.

J Child Neurol. 2003 Sep;18(9):578-90. No abstract available.

PMID:
14572135
16.

Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.

Ramakrishnan H, Hedayati KK, Lüllmann-Rauch R, Wessig C, Fewou SN, Maier H, Goebel HH, Gieselmann V, Eckhardt M.

J Neurosci. 2007 Aug 29;27(35):9482-90.

17.

Stem cell-based cell therapy in neurological diseases: a review.

Kim SU, de Vellis J.

J Neurosci Res. 2009 Aug 1;87(10):2183-200. doi: 10.1002/jnr.22054. Review.

PMID:
19301431
18.
19.

[Pathogenesis and pathomorphology of human leukodystrophies].

Zhabotinskiĭ IuM, Shefer VF.

Arkh Patol. 1981;43(11):86-92. Review. Russian.

PMID:
7032481
20.

Some thoughts on the neurobiology of the leukodystrophies.

Norton WT.

Neuropediatrics. 1984 Sep;15 Suppl:28-31.

PMID:
6100796
Items per page

Supplemental Content

Support Center